Author:
Gao Yelei,Liu Rui,Zhou Qi,Wang Xingmei,Huang Liping,Shi Qianling,Wang Zijun,Lu Shuya,Li Weiguo,Ma Yanfang,Luo Xufei,Fukuoka Toshio,Ahn Hyeong Sik,Lee Myeong Soo,Luo Zhengxiu,Liu Enmei,Chen Yaolong,Shu Chang,Tian Daiying
Abstract
AbstractBackgroundAs COVID-19 has become a global pandemic, early prevention and control of the epidemic is extremely important. Telemedicine, which includes medical advice given over telephone, Internet, mobile phone applications or other similar ways, may be an efficient way to reduce transmission and pressure on medical institutions.MethodsWe searched MEDLINE, Web of science, Embase, Cochrane, CBM, CNKI and Wanfang databases for literature on the use of telemedicine for COVID-19, SARS and MERS. from their inception to March 31st, 2020. We included studies about the content of the consultation (such as symptoms, therapy and prevention, policy, public service), screening of suspected cases, the provision of advice given to those people who may have symptoms or contact history. We conducted meta-analyses on the main outcomes of the studies.ResultsA total of 2041 articles were identified after removing duplicates. After reading the full texts, we finally included nine studies. People were most concerned about symptoms (64.2%), epidemic situation and public problems (14.5%), and psychological problems (10.3%) during COVID-19 epidemic. During the SARS epidemic, the proportions of people asking for consultation for symptoms, prevention and therapy, and psychological problems were 35.0%, 22.0%, and 23.0%, respectively. Two studies demonstrated that telemedicine can be used to screen the suspected patients and give advice. One study emphasized the limited possibilities to follow up people calling hotlines and difficulties in identifying all suspect cases.ConclusionsTelemedicine services should focus on the issues that the public is most concerned about, such as then symptoms, prevention and treatment of the disease, and provide reasonable advice to patients with symptoms or people with epidemic history.
Publisher
Cold Spring Harbor Laboratory
Reference43 articles.
1. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
2. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020[internet] World Health Organization. ;Available online:https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
3. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2;Coronaviridae Study Group of the International Committee on Taxonomy of Viruses.The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-Coronaviridae Study Group of the International Committee on Taxonomy of Viruses;Nat Microbiol,2020
4. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
5. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia